We take a look at science behind widespread but overblown media reports that Botox could be used to treat stomach cancer
A vaccine to prevent infection with a common herpes virus, the Epstein-Barr Virus (EBV), could help prevent 200,000 new cancers worldwide per year.
In the next in our Cancer and Infections series, we look at the stomach bug H. pylori and how it’s linked with cancer.
Can you catch cancer? The answer is no, but you can pick up an infection that increases the chances of developing certain types.
A new type of breath test that detects nanoparticles could help diagnose stomach cancers, according to a study published in the British Journal of Cancer.
Survival for advanced stomach and oesophagael cancer patients increases by 40 per cent when treated with the chemotherapy drug, Docetaxel – providing evidence to prescribe it as a second-line treatment, according to the results of a Cancer Research UK trial presented at the American Society of Clinical Oncology (ASCO) Gastrointestinal cancers symposium today.
Cancer Research UK’s Drug Development Office (DDO), in collaboration with academia and industry, has announced a new trial to open in Oxford. The trial will test an experimental drug from AstraZeneca in patients with advanced oesophago-gastric cancer – a disease for which no well-established standard treatments exist.
Cancer Research UK’s Drug Development Office (DDO) has joined forces with academia and industry to open a clinical trial that will test an experimental drug from AstraZeneca called AZD4547 in combination with standard chemotherapy to treat a group of patients with advanced stomach or oesophageal cancer.
A new centre launched today will cement Oxford’s place at the forefront of cancer research, and form one of the final links in a unique chain of Cancer Research UK Centres across the country.
Cancer patients from deprived backgrounds are more likely to develop life-threatening health problems, research published today (Wednesday) in the British Journal of Cancer* shows.